← Back to all trials
Completed
NCT06418308
Intrathecal Dexmedetomidine vs Epinephrine
Conditions: Cesarean Section, Anesthesia, Spinal
Sex: Female
Ages: 18 Years – 55 Years
Healthy volunteers: No
Phase: PHASE4
Enrollment: 90
Sponsor: Icahn School of Medicine at Mount Sinai
Location: Mount Sinai Hospital New York New York
Summary
Several studies have shown that adding dexmedetomidine or epinephrine to single-dose spinal analgesia preparations improves the length and/or speed of onset of the sensory block and post-operative pain management without increased negative side effects. To date, however, no study has compared adjunctive intrathecal dexmedetomidine to adjunctive intrathecal epinephrine in single-dose spinal analgesia. The purpose of this study is to determine if adjunctive intrathecal dexmedetomidine is non-inferior to adjunctive intrathecal epinephrine in providing better single-dose spinal analgesia during cesarean section.
Eligibility Criteria
Inclusion Criteria:
* Pregnant patients
* aged 18-55 years
* presenting for scheduled primary or secondary cesarean section
* candidates for single shot spinal anesthesia singleton pregnancy
Exclusion Criteria:
* patient refusal of spinal anesthetic
* if patient is not a candidate for spinal anesthesia due to history of coagulopathy, elevated intracranial pressure, infection at site of injection, etc.
* emergency cesarean section
* preexisting motor or sensory deficit
* suspected pre-eclampsia
* patient receiving combined spinal-epidural as anesthetic technique
* BMI \> 40
Source: ClinicalTrials.gov (NCT06418308). StuddyBuddy aggregates publicly available trial information.